Mirae Asset Global ETFs Holdings’s Fennec Pharmaceuticals FENC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Sell	13,372 -249	-2%	-$2.03K	﹤0.01%	2642
2026 Q1	$83.8K	Buy	13,621 +2,748	+25%	+$21.2K	﹤0.01%	2745
2025 Q4	$83.7K	Sell	10,873 -20	-0.2%	-$164	﹤0.01%	2752
2025 Q3	$102K	Sell	10,893 -2,024	-16%	-$17.5K	﹤0.01%	2648
2025 Q2	$107K	Sell	12,917 -1,149	-8%	-$7.86K	﹤0.01%	2576
2025 Q1	$85.7K	Buy	14,066 +624	+5%	+$4.01K	﹤0.01%	2698
2024 Q4	$85K	Buy	13,442 +608	+5%	+$3.11K	﹤0.01%	2766
2024 Q3	$64.2K	Buy	12,834 +3,072	+31%	+$17.8K	﹤0.01%	2865
2024 Q2	$59.6K	Buy	+9,762	New	+$81.1K	﹤0.01%	2743

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's FENC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Fennec Pharmaceuticals (FENC) stake by 1.8% in Q2 2026, selling an estimated $2.03K and leaving 13,372 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Mirae Asset Global ETFs Holdings first reported a position in FENC in Q2 2024 and has held it in 9 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Mirae Asset Global ETFs Holdings held 13,372 shares of Fennec Pharmaceuticals worth $144K as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 249 Fennec Pharmaceuticals shares in Q2 2026, an estimated $2.03K.
Fennec Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2642 holding.
Mirae Asset Global ETFs Holdings first reported a position in Fennec Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.